Adverse effects of gender‐affirming hormonal therapy in transgender persons: Assessing reports in the French pharmacovigilance database-Reference-Cited by-同舟云学术

Adverse effects of gender‐affirming hormonal therapy in transgender persons: Assessing reports in the French pharmacovigilance database

Author:

Yelehe Melissa¹^ORCID,Klein Marc²,El Aridi Layal³,Maurier Anaïs⁴,Gillet Pierre¹⁵^ORCID,Feigerlova Eva²⁶^ORCID

Affiliation:

1. Department of Clinical Pharmacology and Toxicology Centre Régional de Pharmacovigilance de Lorraine Nancy France

2. Department of Endocrinology, Diabetology and Nutrition, Centre Hospitalier Universitaire and Medical Faculty Université de Lorraine Nancy France

3. Centre Régional de Pharmacovigilance de Brest Centre Hospitalier Universitaire de Brest Brest France

4. Centre Régional de Pharmacovigilance et d'Information sur le Médicament Centre Val de Loire Centre Hospitalier Universitaire de Tours Tours France

5. CNRS, IMoPA Université de Lorraine Nancy France

6. INSERM UMR_S 1116 ‐ DCAC Université de Lorraine Nancy France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference39 articles.

1. International Classification of Diseases 11th Revision.https://icdwhoint2018(last accessed 12 May 2022)

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Multiple drugs;Reactions Weekly;2023-04-01